Zhengye Biotechnology Holding Ltd (ZYBT) is the 13th largest of 26 Animal Health companies by market capitalisation, at 74.81 Mn, behind Immucell Corp /De/ at 88.88 Mn. The table below compares all 26 on 8 financial metrics.
| # | Ticker | Company | match | industry_code | industry_group | industry_group_code | Market Capitalization | P/E | P/S | Enterprise Value |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | IDXX | Idexx Laboratories Inc /De | primary | H-05 | Pharmaceuticals and Biotechnology | HG-01 | 40.89 Bn | 35.88 | 8.98 | 40.69 Bn |
| 2 | ZTS | Zoetis Inc. | primary | H-05 | Pharmaceuticals and Biotechnology | HG-01 | 30.74 Bn | 9.40 | 3.23 | 29.07 Bn |
| 3 | ELAN | Elanco Animal Health Inc | primary | H-05 | Pharmaceuticals and Biotechnology | HG-01 | 11.90 Bn | -59.79 | 2.37 | 11.37 Bn |
| 4 | PAHC | Phibro Animal Health Corp | primary | H-05 | Pharmaceuticals and Biotechnology | HG-01 | 1.50 Bn | 15.04 | 0.99 | 1.42 Bn |
| 5 | ICCC | Immucell Corp /De/ | primary | H-05 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | -209.23 | 3.32 | 0.08 Bn |
| 6 | ZYBT | Zhengye Biotechnology Holding Ltd | primary | H-05 | Pharmaceuticals and Biotechnology | HG-01 | 0.07 Bn | -8.90 | 4.59 | 0.07 Bn |
| 7 | GIPL | Global Innovative Platforms Inc. | primary | H-05 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -36.02 | 132.88 | 0.02 Bn |
| 8 | MRK | Merck & Co., Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 364.65 Bn | 115.07 | 5.48 | 357.51 Bn |
| 9 | COR | Cencora, Inc. | secondary | H-19 | Healthcare Payers and Distributors | HG-05 | 62.79 Bn | 23.79 | 0.19 | 59.98 Bn |
| 10 | CHWY | Chewy, Inc. | secondary | S-04 | Branded Foods | SG-02 | 8.66 Bn | 33.95 | 0.67 | 8.14 Bn |
| 11 | NEOG | Neogen Corp | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 2.60 Bn | -366.64 | 2.98 | 2.41 Bn |
| 12 | BFLY | Butterfly Network, Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 1.99 Bn | -26.60 | 17.75 | 1.86 Bn |
| 13 | ANIK | Anika Therapeutics, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.28 Bn | -131.14 | 2.31 | 0.24 Bn |
| 14 | VANI | Vivani Medical, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.12 Bn | -4.27 | — | 0.10 Bn |
| 15 | GNVR | Genvor Inc | secondary | M-05 | Chemicals | MG-01 | 0.03 Bn | -7.21 | — | 0.02 Bn |
| 16 | RDGL | Vivos Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.02 Bn | -8.86 | 399.68 | 0.02 Bn |
| 17 | CTSO | Cytosorbents Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.02 Bn | -1.06 | 0.52 | 0.01 Bn |
| 18 | ALRTF | ALR Technologies SG Ltd. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.01 Bn | -0.55 | — | 0.01 Bn |
| 19 | AIMD | Ainos, Inc. | secondary | T-15 | Computer Hardware | TG-02 | 0.01 Bn | -0.75 | 800.63 | 0.01 Bn |
| 20 | GELS | Gelteq Ltd | secondary | H-12 | Pharma Services | HG-03 | 0.01 Bn | — | — | 0.01 Bn |
| 21 | SNOA | Sonoma Pharmaceuticals, Inc. | secondary | H-07 | Medical Devices and Diagnostics | HG-02 | 0.01 Bn | -2.26 | 0.23 | 0.00 Bn |
| 22 | CANF | Can-Fite BioPharma Ltd. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.24 | 5.93 | 0.00 Bn |
| 23 | VNRX | Volitionrx Ltd | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.00 Bn | -0.09 | 0.62 | 0.00 Bn |
| 24 | VRAX | Virax Biolabs Group Ltd | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.00 Bn | -0.19 | 84.17 | -0.01 Bn |
| 25 | CDT | CDT Equity Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.01 | — | 0.00 Bn |
| 26 | JAGX | Jaguar Health, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.01 | 0.01 | -0.01 Bn |